Reining in the Cost of Cancer Care

Video

For High-Definition, Click

Rising healthcare costs represent a national challenge and a “call to action,” which requires collaboration across platforms to devise practical solutions while keeping patients’ best interests at heart, says Andrew L. Pecora, MD.

Oncology physicians share in this responsibility, says the doctor. He has been involved in the creation of the Cancer Outcomes Tracking Analysis (COTA), a health outcomes measurement and tracking tool that Pecora says enables physicians to achieve the “Goldilocks” target—neither too much care, nor too little.

Pecora says his fellow physicians have contributed to the development of the Centers for Medicare & Medicaid Services’ Oncology Care Model of improving value and reducing expense, along with other types of reimbursement models.

Related Videos
Sangeeta Goswami, MD, PhD, of The University of Texas MD Anderson Cancer Center
Pasi A. Jänne, MD, PhD, discusses an exploratory analysis from the FLAURA2 trial of osimertinib plus chemotherapy in treatment-naive, EGFR-mutant NSCLC.
Andrew Ip, MD
Arya Amini, MD
Adrianna Masters, MD, PhD,
Chul Kim, MD, MPH
Andrew Ip, MD
In this final episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, discuss a roadmap of artificial intelligence (AI) advances in the next 5 to 10 years.
In this eighth episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, explain how artificial intelligence tools are being developed to match the right patient to the right drug on the right clinical trial.